Topics:
Arthritis|Imaging In Rheumatology|Lupus|Psoriatic Arthritis|Women's Health And Rheumatology|Geriatrics|Gout|Browse All Topics

Rheumatology Network

Tech Tips Series #1: Managing the Information Barrage

Our goal at RheumNet is always to help you manage the constant flood of online information for rheumatologists. Here, in the first installment of a new series, Advisory Board member Suleman Bhana MD shares tips for saving, sorting, and retrieving journal articles.

Recent Content

psoriatic arthritis

Interleukin Inhibitors in Brief

February 25, 2015 | Psoriatic Arthritis, Arthritis, Spondyloarthritis

Agents that target the TH17-interleukin pathway show promise in psoriatic arthritis, as alternatives for patients who don't benefit from TNFα blockers. This slide show describes their mode of action and potential.

More Guidance on Safe Opioid Use

Norman Bauman
February 24, 2015 | Rheumatologic Pain, Musculoskeletal Citations, Osteoarthritis, Rheumatoid Arthritis
By

Articles in two different internal medicine journals last week discussed when and how to use opioids for rheumatologic pain, despite their hazards and limitations.

Baricitinib Excels Placebo for RA in Second Phase 3 Trial

Lois Wingerson
News | February 23, 2015 | Rheumatoid Arthritis, Arthritis
By

The JAK1 and JAK2 inhibitor baricitinib has shown significant results in a second Phase 3 trial for rheumatoid arthritis.

In PsA, Are You Minimizing What You Can't See?

Rita Baron-Faust
February 23, 2015 | Psoriatic Arthritis, Arthritis, Musculoskeletal Citations
By

The first study to ask about variance between physicians and patients in judging the severity of psoriatic arthritis shows that, as with rheumatoid arthritis, they don't reach similar conclusions.

prior authorization

Rheumatologists! Unite Against the Formulary Police!

Christopher Adams MD
February 23, 2015 | Rheumatic Diseases, Myositis, Psoriatic Arthritis, Rheumatoid Arthritis, Spondyloarthritis, Systemic Sclerosis, Vasculitis
By

Prior authorizations have begun to spread pandemic-like from high-cost biologics to treatments used routinely in rheumatology. The time burden on rheumatologists is insupportable, contends the author, who says it's time to take action.

Infliximab Biosimilars Launch in Europe. (So What?)

Lothar M. Kirsch MD
News | February 23, 2015 | Rheumatoid Arthritis, Psoriatic Arthritis, Spondyloarthritis
By

Two biosimilars for the TNF inhibitor infliximab are now licensed and distributed in Europe. A German rheumatologist wonders what difference the option to prescribe Inflektra and Remsima will make, if any.

low back pain

Surprising News About Low Back Pain

Rita Baron-Faust
News | February 20, 2015 | Osteoarthritis, Musculoskeletal Citations, Rheumatologic Pain, Spondyloarthritis
By

Do you think heavy lifting with degenerative osteoarthritis is the major cause of low back pain? A new study designed to identify modifiable triggers finds relative youth, time of day, and perhaps lack of planning to be key factors.

View More Videos
View More Slideshows

By clicking Accept, you agree to become a member of the UBM Medica Community.